相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial
William T. Cefalu et al.
LANCET (2013)
A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of randomized trials
Giovanni Musso et al.
ANNALS OF MEDICINE (2012)
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Silvio E. Inzucchi et al.
DIABETES CARE (2012)
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
S. E. Inzucchi et al.
DIABETOLOGIA (2012)
Drug-induced hypoglycaemia in type 2 diabetes
Berit Inkster et al.
EXPERT OPINION ON DRUG SAFETY (2012)
Hypoglycaemia: a therapeutic concern in type 2 diabetes
Alan J. Garber
LANCET (2012)
2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial
Baptist Gallwitz et al.
LANCET (2012)
Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes
Christine Clar et al.
BMJ OPEN (2012)
Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus
Jean M. Whaley et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2012)
Patient preferences for diabetes management among people with type 2 diabetes in Denmark - a discrete choice experiment
Mette Bogelund et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin A randomized, 52-week, double-blind, active-controlled noninferiority trial
Michael A. Nauck et al.
DIABETES CARE (2011)
Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes
Rena R. Wing et al.
DIABETES CARE (2011)
Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients
Giuseppe Derosa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans
James F. List et al.
KIDNEY INTERNATIONAL (2011)
The Impact of Non-Severe Hypoglycemic Events on Work Productivity and Diabetes Management
Meryl Brod et al.
VALUE IN HEALTH (2011)
Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1
Jeroen P. Jansen et al.
VALUE IN HEALTH (2011)
Understanding the inter-relationship between improved glycaemic control, hypoglycaemia and weight change within a long-term economic model
P. McEwan et al.
DIABETES OBESITY & METABOLISM (2010)
Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study
D. R. Matthews et al.
DIABETES OBESITY & METABOLISM (2010)
Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life
Michael F. Pollack et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Exenatide Versus Glibenclamide in Patients with Diabetes
G. Derosa et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2010)
A comparison of efficacy and safety of vildagliptin and gliclazide in combination with metformin in patients with Type 2 diabetes inadequately controlled with metformin alone: a 52-week, randomized study
C. Filozof et al.
DIABETIC MEDICINE (2010)
Relationship of baseline HbA1c and efficacy of current glucose-lowering therapies: a meta-analysis of randomized clinical trials
R. A. DeFronzo et al.
DIABETIC MEDICINE (2010)
Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial
B. Goke et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes
A. H. Barnett et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Effect of Noninsulin Antidiabetic Drugs Added to Metformin Therapy on Glycemic Control, Weight Gain, and Hypoglycemia in Type 2 Diabetes
Olivia J. Phung et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Checking consistency in mixed treatment comparison meta-analysis
S. Dias et al.
STATISTICS IN MEDICINE (2010)
Hypoglycemia and Clinical Outcomes in Patients With Diabetes Hospitalized in the General Ward
Alexander Turchin et al.
DIABETES CARE (2009)
Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose-lowering agents
A. B. Hauber et al.
DIABETIC MEDICINE (2009)
Diabetes medications and body weight
Joanna Mitri et al.
EXPERT OPINION ON DRUG SAFETY (2009)
A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered
Georgia Salanti et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2009)
The Impact of Weight Gain on Motivation, Compliance, and Metabolic Control in Patients with Type 2 Diabetes Mellitus
F. Xavier Pi-Sunyer
POSTGRADUATE MEDICINE (2009)
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M. Nathan et al.
DIABETES CARE (2009)
Performing meta-analysis with incomplete statistical information in clinical trials
Jianbing Ma et al.
BMC MEDICAL RESEARCH METHODOLOGY (2008)
Glycemic control in diabetes: A tale of three studies
Zachary T. Bloomgarden
DIABETES CARE (2008)
Rosiglitazone no longer recommended
[Anonymous]
LANCET (2008)
Evaluation of networks of randomized trials
Georgia Salanti et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2008)
Meta-analysis of mixed treatment comparisons at multiple follow-up times
G. Lu et al.
STATISTICS IN MEDICINE (2007)
Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration
S. R. Heller et al.
DIABETOLOGIA (2007)
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial
M. A. Nauck et al.
DIABETES OBESITY & METABOLISM (2007)
Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes
Craig J. Currie et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes
B Charbonnel et al.
DIABETOLOGIA (2005)
Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study
DR Matthews et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2005)
Assessing the value of weight loss among primary care patients
CC Wee et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2004)
Bayesian measures of model complexity and fit
DJ Spiegelhalter et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2002)
分享论文
